💧GOTA🦶
🔹 Artritis inflamatoria por depósito de cristales de urato monosódico cuando AU >6.8 mg/dL.
🔹 Fisiopatología: hiperuricemia (infraexcreción renal, base genética) → activación inmune → crisis dolorosa, tofos y erosiones.
🔹 Dx: cristales UMS en líquido sinovial (gold standard); AU puede ser normal en la crisis. US (doble contorno) y DECT ayudan.
🔹 Tx: crisis: AINEs, colchicina o corticoides. Crónico: bajar AU <6 mg/dL (alopurinol 1ª línea; febuxostat). Profilaxis al iniciar ULT.
🔹 Novedad: iSGLT2 ↓ urato y ↓ crisis/hospitalizaciones; énfasis en treat-to-target y titulación lenta.
📚 FitzGerald JD. Gout. Ann Intern Med (In the Clinic). 2025. doi:10.7326/ANNALS-24-03951
✅️Descarga aquí el pdf completo y Únete:https://t.co/alf9aGqxny
The most common chronic liver disease worldwide, metabolic dysfunction–associated steatotic liver disease (MASLD) affects approximately 30% to 40% of the general adult population.
This Review summarizes the diagnosis, treatment, and prognosis of MASLD. https://t.co/cnge8XGwQ6
It’s an honor to promote free education in Musculoskeletal Ultrasound (#MSUS) and Rheumatology.
We are happy to share the MSUS Database: over 1,000 images and videos of sonoanatomy and pathology, accessible with a single click from anywhere in the world 🌍 🌎 , even where there’s no textbook, mentor, or ultrasound machine, so students, residents, and practicing physicians can learn and compare cases in real time.
In the MSUS Database you will find:
1️⃣Shoulder Anatomy and Pathology
2️⃣Elbow Anatomy and Pathology
3️⃣Hand Anatomy and Pathology
4️⃣Hip Anatomy and Pathology
5️⃣Knee Anatomy and Pathology
6️⃣Foot Anatomy and Pathology
7️⃣Spine
8️⃣Soft Tissue
9️⃣Nerves
🔟Muscle
1️⃣1️⃣Interventional
1️⃣2️⃣Hyaluronic Acid
1️⃣3️⃣PRP
1️⃣4️⃣Doppler
1️⃣5️⃣Elastography
1️⃣6️⃣Trauma
1️⃣7️⃣Rheumatoid Arthritis
1️⃣8️⃣CPPD
1️⃣9️⃣And more…
📸 🎥 We’re expanding this library every week to its improvement! 🤝🌍
Special thanks to Giorgio Tamborrini of UZR Ultrasound Center (@rheumatology) for conceiving and leading this project and inviting me to contribute. It’s also a privilege to collaborate with MSUS experts such as:
🔹Dr. Jörg Dünkel of @SportklinikBern
🔹Dr. Alberto Schek @aschek3582
🔗 Explore & share: https://t.co/QYhHBlw5dz
❗️To find specific images or videos, go to the Photostream and use the 🔎 (magnifying glass) icon just below 👇 the “secondary menu”, or explore each album individually in its dedicated folder 📂
#MSUSDatabase #GlobalUltrasound #POCUS #FreeEducation #Rheumatology #MSUS #OpenEducation #FOAMed #USguidedInjections #PRP #SportsMed
🔍 ANA Positive - What Next? (2025 Approach)
ANA is a screening tool, not a diagnosis.
A simple, practical algorithm to avoid over-calling autoimmune disease:
1️⃣ Check clinical context
2️⃣ Look at titer & pattern
3️⃣ Order reflex antibodies
4️⃣ Correlate with symptoms - never by ANA alone
5️⃣ Classify into 3 outcomes
Infographic by Dr. Aravind Palraj
#Rheumatology #MedTwitter @DrAkhilX @IhabFathiSulima #MedicalEducation #FOAMed #SLE
Dapagliflozina 10 mg/día induce una glucosuria promedio de 78 ± 8 g/día (≈300 kcal), en pacientes con DM2 y FG normal
Equivale a 60 min/día de caminata rápida.
Pérdida de peso: 2.5 ± 0.6 kg a 24 semanas, principalmente grasa visceral.
DOI:10.1172/JCI72227
👇🏽
🚨 Deep Dive into IgG4-Related Disease (IgG4-RD) from Nature Reviews Rheumatology!
•🌟 What is IgG4-RD? A sneaky fibro-inflammatory disorder hitting multiple organs with slow-growing, pseudo-tumoural lesions—think hidden troublemakers!
•⚠️ Diagnosis Challenge: No gold-standard criteria! Needs a detective-like approach—blend clinical signs, radiology, and serology to ditch mimics like histiocytoses, vasculitis, and lymphoproliferative disorders.
•🎯 Subphenotypes: Spot the variety—Mikulicz (swollen glands), head-neck limited, pancreato-hepato-biliary (jaundice alert!), retroperitoneal/aortic—each with unique patient profiles, symptoms, and IgG4 levels!
•💊 Treatment: Glucocorticoids lead the charge, but B cell-depleting champs (rituximab, inebilizumab) and cytokine-targeting drugs are stealing the spotlight—most still in hot clinical trials!
•🔄 Chronic Nature: A relapsing rogue—demands vigilant, long-term follow-up to keep it in check!
•📊 Fun Fact: Hits men harder (2:1-3:1 ratio) with a vascular vibe—50% cases show large/medium artery involvement, even small vessels!
•🕵️ History Bite: Born in 2001 with autoimmune pancreatitis link—evolved into a systemic puzzle by 2003, tying sclerosing pancreatitis, Riedel thyroiditis, and more!
•🩺 Symptoms Spotlight: Jaundice, proptosis, abdominal pain, or cranial neuropathies—depends on the organ hit, making it a diagnostic rollercoaster!
•🔬 Histology Clue: Fibrosis + chronic inflammation = IgG4-RD signature—seen on FDG-PET-CT for activity tracking!
•🌐 Research Edge: Ongoing trials push boundaries with monoclonal antibodies—stay tuned for breakthroughs!
#IgG4RD #Rheumatology #AutoimmuneDisease #MedicalResearch #HealthInnovation #RareDisease #ClinicalTrials
https://t.co/bgqYTrDeZn
Relationship of sarcoidosis with other immune-mediated diseases
◦ #Sarcoidosis patients are more likely to have a history of #immune-mediated diseases (IMD) and have an increased risk of IMD after sarcoidosis diagnosis.
◦ There is a wide diversity of IMDs across several organ systems which have been observed to co-occur with sarcoidosis, including #autoimmune #rheumatic diseases such as ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, systemic sclerosis, Sjögren's disease, systemic lupus erythematosus, vasculitis, antiphospholipid syndrome, and inflammatory myopathies.
◦ Compared to other IMDs, it is unique for sarcoidosis that the male to female ratio is approximately 1 to 1, and that males tend to receive their diagnosis at a younger age than females.
◦ Sarcoidosis risk is increased in first degree relatives of patients with IMD, indicating some genetic overlap.
📸 Associations between sarcoidosis and immune-mediated diseases grouped by organ system.
*Arkema EV, Rossides M, Cozier YC. Sarcoidosis and its relation to other immune-mediated diseases: Epidemiological insights. J Autoimmun. 2024;149:103127.
🔗https://t.co/ZnaCMG2PdV
🚨🧠🩸Manejo del ictus isquémico agudo en el servicio de urgencias: optimización del cerebro-2025✅
📚DOI:10.1186/s12245-024-00780-5
⚡️PDF👇https://t.co/i3gGexLm56
Full read review of Hydryoxychloroquine -its pharmacology, MOA (eg, blocking TLR 7 & 9), Dz specific efficacy and adverse effects https://t.co/WVErW1RrCj
💯 ¡Ya está disponible el #webinar: La sexualidad en enfermedades reumáticas: claves y retos a afrontar!
Si no pudiste verlo o, simplemente, quieres volver a consultarlo, ya puedes acceder a él. https://t.co/pa9k7br9Bq
✔️ Encontrarás claves y consejos para mejorar este aspecto de la vida de las personas con enfermedades reumáticas.
The new issue of Mediterranean Journal of Rheumatology with 17 new informative articles has been published. Worthy to read and explore! https://t.co/DadLuHyBHQ . Submit your paper today! No fees, open access, papers in Pubmed! An excellent tool for researchers!